Do drug companies suppress unfavorable results from academic journals?
In short: yes. A study by Rising, Bacchetti, Bero (2008) compares mandatory trial submissions to the FDA with information on trials which appear in academic journals. The authors find that “Discrepancies between the trial information reviewed by the FDA and information found in published trials tended to lead to more favorable presentations of the NDA drugs…